Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORAL-21Standard

AVERI

DESOGESTREL; ETHINYL ESTRADIOL

Standard Dose
0.15MG;0.03MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AVERI is listed in Drugs@FDA under application 218933 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DESOGESTREL; ETHINYL ESTRADIOL Form and strength TABLET;ORAL-21 - 0.15MG;0.03MG Sponsor AVION PHARMS Submission history Latest submission status date: 2025-05-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview AVERI is listed in Drugs@FDA under application 218933 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DESOGESTREL; ETHINYL ESTRADIOL Form and strength TABLET;ORAL-21 - 0.15MG;0.03MG Sponsor AVION PHARMS Submission history Latest submission status date: 2025-05-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.